Enveda Raises $311M—Its AI Drugs Still Face the Clinical Test

This event underscores investment in AI for drug discovery, emphasizing the critical need for clinical validation to ensure safety and efficacy.

Auto-scored: Low-risk AI development in medicine with only reassurance-level mitigation.